Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

Go back to Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
Illumina, Inc. (NASDAQ: ILMN) Delayed: 218.38 -3.28 (1.48%)
Previous Close $221.66    52 Week High $196.47 
Open $216.74    52 Week Low $127.10 
Day High $219.58    P/E 242.64 
Day Low $213.95    EPS $0.90 
Volume 1,145,947